- Home
- GILD vs FI Comparison
GILD vs FI Comparison
Compare GILD & FI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- FI
- Stock Information
- Founded
- GILD 1987
- FI 1984
- Country
- GILD United States
- FI United States
- Employees
- GILD N/A
- FI N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- FI Business Services
- Sector
- GILD Health Care
- FI Consumer Discretionary
- Exchange
- GILD Nasdaq
- FI Nasdaq
- Market Cap
- GILD 113.0B
- FI 124.0B
- IPO Year
- GILD 1992
- FI 1986
- Fundamental
- Price
- GILD $92.98
- FI $206.38
- Analyst Decision
- GILD Buy
- FI Buy
- Analyst Count
- GILD 26
- FI 25
- Target Price
- GILD $96.71
- FI $219.92
- AVG Volume (30 Days)
- GILD 6.4M
- FI 3.2M
- Earning Date
- GILD 02-11-2025
- FI 02-04-2025
- Dividend Yield
- GILD 3.38%
- FI N/A
- EPS Growth
- GILD N/A
- FI 8.67
- EPS
- GILD 0.10
- FI 5.19
- Revenue
- GILD $28,299,000,000.00
- FI $20,122,000,000.00
- Revenue This Year
- GILD $6.54
- FI $3.48
- Revenue Next Year
- GILD N/A
- FI $8.47
- P/E Ratio
- GILD $937.76
- FI $38.97
- Revenue Growth
- GILD 3.31
- FI 6.99
- 52 Week Low
- GILD $62.07
- FI $131.41
- 52 Week High
- GILD $98.90
- FI $223.23
- Technical
- Relative Strength Index (RSI)
- GILD 52.30
- FI 40.96
- Support Level
- GILD $90.27
- FI $201.61
- Resistance Level
- GILD $93.59
- FI $208.28
- Average True Range (ATR)
- GILD 2.12
- FI 3.76
- MACD
- GILD -0.21
- FI -1.32
- Stochastic Oscillator
- GILD 50.91
- FI 9.36
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About FI Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.